Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BJDXNASDAQ:CODXNASDAQ:NURONASDAQ:SSKN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBJDXBluejay Diagnostics$1.66+2.2%$1.75$1.46▼$37.50$2.47M0.47661,710 shs10,134 shsCODXCo-Diagnostics$0.29+0.3%$0.30$0.23▼$2.23$9.64M0.6249,742 shs384,882 shsNURONeuroMetrix$4.55+4.4%$4.54$2.66▼$4.73$9.37M1.8216,608 shs35,522 shsSSKNStrata Skin Sciences$2.38-7.8%$2.46$2.10▼$3.80$9.93M0.6913,568 shs30,244 shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBJDXBluejay Diagnostics0.00%+2.16%-26.44%-77.93%-94.45%CODXCo-Diagnostics0.00%+9.33%-4.37%-10.28%-77.04%NURONeuroMetrix0.00%0.00%0.00%+3.88%+22.97%SSKNStrata Skin Sciences0.00%+4.11%-2.06%-10.19%-22.98%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBJDXBluejay Diagnostics0.0989 of 5 stars0.02.00.00.00.60.00.6CODXCo-Diagnostics3.6967 of 5 stars3.55.00.04.40.00.01.3NURONeuroMetrixN/AN/AN/AN/AN/AN/AN/AN/ASSKNStrata Skin Sciences2.8374 of 5 stars3.55.00.00.00.61.70.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBJDXBluejay Diagnostics 0.00N/AN/AN/ACODXCo-Diagnostics 3.00Buy$5.501,816.38% UpsideNURONeuroMetrix 0.00N/AN/AN/ASSKNStrata Skin Sciences 3.00Buy$6.00152.10% UpsideCurrent Analyst Ratings BreakdownLatest BJDX, SSKN, NURO, and CODX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/28/2025CODXCo-DiagnosticsD Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy4/28/2025CODXCo-DiagnosticsD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$10.00(Data available from 7/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBJDXBluejay Diagnostics$250K9.86N/AN/A$10.34 per share0.16CODXCo-Diagnostics$3.91M2.46N/AN/A$1.70 per share0.17NURONeuroMetrix$3.03M3.09N/AN/A$13.18 per share0.35SSKNStrata Skin Sciences$33.56M0.30N/AN/A$1.19 per share2.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBJDXBluejay Diagnostics-$7.72M-$379.74N/A∞N/AN/A-322.46%-262.96%8/13/2025 (Estimated)CODXCo-Diagnostics-$37.64M-$1.17N/AN/AN/A-1,025.45%-60.16%-52.69%8/6/2025 (Estimated)NURONeuroMetrix-$6.53M-$4.59N/A∞N/A-203.71%-42.56%-39.26%8/4/2025 (Estimated)SSKNStrata Skin Sciences-$10.09M-$2.27N/AN/AN/A-27.22%-138.22%-24.37%8/13/2025 (Estimated)Latest BJDX, SSKN, NURO, and CODX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025SSKNStrata Skin Sciences-$0.56-$0.58-$0.02-$0.58$7.28 million$6.81 million5/13/2025Q1 2025BJDXBluejay DiagnosticsN/A-$3.37N/A-$3.37N/AN/A5/8/2025Q1 2025CODXCo-Diagnostics-$0.33-$0.24+$0.09-$0.24$0.38 million$0.05 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBJDXBluejay DiagnosticsN/AN/AN/AN/AN/ACODXCo-DiagnosticsN/AN/AN/AN/AN/ANURONeuroMetrixN/AN/AN/AN/AN/ASSKNStrata Skin SciencesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBJDXBluejay DiagnosticsN/A2.712.71CODXCo-DiagnosticsN/A4.434.23NURONeuroMetrixN/A13.8812.70SSKNStrata Skin Sciences5.711.050.87Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBJDXBluejay Diagnostics18.47%CODXCo-Diagnostics14.99%NURONeuroMetrix19.40%SSKNStrata Skin Sciences32.43%Insider OwnershipCompanyInsider OwnershipBJDXBluejay Diagnostics0.08%CODXCo-Diagnostics6.10%NURONeuroMetrix7.30%SSKNStrata Skin Sciences39.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBJDXBluejay Diagnostics91.49 million1.49 millionNot OptionableCODXCo-Diagnostics10033.57 million31.53 millionOptionableNURONeuroMetrix202.06 million1.90 millionNot OptionableSSKNStrata Skin Sciences1204.17 million2.54 millionNot OptionableBJDX, SSKN, NURO, and CODX HeadlinesRecent News About These CompaniesStrata Skin Sciences (NASDAQ:SSKN) and 111 (NASDAQ:YI) Head-To-Head AnalysisJune 27, 2025 | americanbankingnews.comSSKN STRATA Skin Sciences, Inc. - Seeking AlphaJune 24, 2025 | seekingalpha.comSTRATA Skin Sciences Gains CPT Code Expansion For Excimer Laser Use In Skin Inflammatory DiseasesMay 21, 2025 | nasdaq.comSTRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q1 2025 Earnings Call TranscriptMay 16, 2025 | insidermonkey.comSTRATA Skin Sciences, Inc. (SSKN) Q1 2025 Earnings Call TranscriptMay 14, 2025 | seekingalpha.comSTRATA Skin Sciences Reports First Quarter 2025 Financial Results and Provides a Corporate UpdateMay 14, 2025 | globenewswire.com3SSKN : A Peek at Strata Skin Sciences's Future EarningsMay 13, 2025 | benzinga.comStrata Skin Sciences Inc (SSKN) Q1 2025: Everything You Need To Know Ahead Of EarningsMay 13, 2025 | finance.yahoo.comSTRATA Skin Sciences to Join D. Boral Capital’s Inaugural Global Conference in NYCMay 11, 2025 | msn.comSTRATA Skin Sciences to Announce Q1 2025 Financial Results and Host Investor CallMay 11, 2025 | msn.comSTRATA Skin Sciences to Report First Quarter 2025 Financial Results on May 14, 2025 and Provide Corporate UpdateMay 9, 2025 | seekingalpha.comSTRATA Skin Sciences to Participate in the D. Boral Capital Inaugural Global ConferenceMay 8, 2025 | globenewswire.comSTRATA Skin Sciences to Report First Quarter 2025 Financial Results on May 14, 2025 and Provide Corporate UpdateMay 7, 2025 | globenewswire.comStrata Skin Sciences price target lowered to $14 from $16 at LadenburgMarch 31, 2025 | markets.businessinsider.comEarnings call transcript: STRATA Skin Sciences Q4 2024 revenue rises 10%March 29, 2025 | uk.investing.comSTRATA Skin Sciences Full Year 2024 Earnings: Revenues Beat Expectations, EPS LagsMarch 29, 2025 | finance.yahoo.comSTRATA SKIN SCIENCES Earnings Results: $SSKN Reports Quarterly EarningsMarch 29, 2025 | nasdaq.comStrata Skin Sciences (SSKN) Gets a Buy from Maxim GroupMarch 29, 2025 | markets.businessinsider.comSTRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q4 2024 Earnings Call TranscriptMarch 29, 2025 | insidermonkey.comSTRATA Skin Sciences Reports Strong Q4 Growth and Strategic ProgressMarch 29, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBJDX, SSKN, NURO, and CODX Company DescriptionsBluejay Diagnostics NASDAQ:BJDX$1.66 +0.04 (+2.16%) Closing price 07/3/2025 03:35 PM EasternExtended Trading$1.62 -0.03 (-2.11%) As of 04:03 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Bluejay Diagnostics, Inc., a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, it develops IL-6 for the monitoring of disease progression in critical care; as well as hsTNT/I and NT-proBNP for the monitoring of patients acuity with chest pain. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.Co-Diagnostics NASDAQ:CODX$0.29 +0.00 (+0.35%) Closing price 07/3/2025 03:47 PM EasternExtended Trading$0.28 -0.01 (-2.09%) As of 04:35 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.NeuroMetrix NASDAQ:NURO$4.55 +0.19 (+4.36%) Closing price 05/1/2025Extended Trading$4.55 0.00 (0.00%) As of 05/1/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.Strata Skin Sciences NASDAQ:SSKN$2.38 -0.20 (-7.75%) Closing price 07/3/2025 01:00 PM EasternExtended Trading$2.38 0.00 (0.00%) As of 04:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Correction Equals Opportunity in Domino’s Pizza Stock Why Occidental's Price Dip Signals a Buying Opportunity Qualcomm’s Hold Rating Misses Strong Growth Story Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
